About

Publications While At HealthPartners

Highlights

selected publications

Journal Article

An open label phase II study of safety and clinical activity of naltrexone for treatment of hormone refractory metastatic breast cancer. 

Investigational New Drugs. 2023

Contact

full name

T. Haddad

Quick Info

Publications

Publications in the past 10 years based solely on publications while at HealthPartners. Publications in prior years appear in grey.

Collaboration

Co-author network

Map of science